ExchangeDEX+
Buy CryptoMarketsSpotFuturesGOLDEarnEvent Center
More
ICP Zero-Fee Gala
Built on nearly a decade of real-world hormone data, Mira’s Hormone Monitor lays the foundation for a future home lab for longevity, metabolic health, and proactiveBuilt on nearly a decade of real-world hormone data, Mira’s Hormone Monitor lays the foundation for a future home lab for longevity, metabolic health, and proactive

Mira Named CES Innovation Awards Honoree for At-Home Lab-Quality Hormone Testing

Author: AI JournalSource: AI Journal
2026/01/06 04:45
Mira
MIRA$0.1011-4.17%
Whalebit
CES$0.7056-0.02%
LAB
LAB$0.13354-0.60%
RealLink
REAL$0.06012-1.31%
FUTURECOIN
FUTURE$0.08204-3.58%

Built on nearly a decade of real-world hormone data, Mira’s Hormone Monitor lays the foundation for a future home lab for longevity, metabolic health, and proactive care

SAN FRANCISCO and LAS VEGAS, Jan. 5, 2026 /PRNewswire/ — Mira, a leader in at-home hormone health, today announced that its Ultra4™ Hormone Monitor has been named a CES Innovation Awards® 2026 Honoree in Digital Health.

Ultra4 delivers lab-quality hormone testing at home, measuring four key hormones with the same technology used in clinical laboratories. The award recognizes both the breakthrough device and Mira’s broader vision to bring real hormonal intelligence into the home.

Ultra4 is the first consumer hormone monitor capable of measuring FSH, LH, E3G, and PdG using fluorescent immunoassay technology. With a single 16-minute test and one device, it provides insights previously only available through repeated bloodwork.

Soft-launched in August, Ultra4 has already been used for tens of thousands of tests, validating strong consumer demand for deeper, continuous hormone data. In early user feedback, 91% of Ultra4 users reported a better understanding of the root cause of their symptoms, including fatigue, mood changes, and irregular cycles.

Ultra4 is powered by Mira’s Hormone Intelligence™ Platform, trained on more than 30 million real-world hormone data points collected over nearly a decade. What began as a fertility solution has evolved into a broader understanding of how hormones influence energy, mood, metabolism, and long-term health.

This data foundation enables Mira’s next step: creating the first true at-home health lab. Rather than testing a single biomarker or fluid in isolation, Mira is developing an integrated system that can read hormonal, metabolic, and biological signals together – across urine, blood, and saliva – within one connected home experience.

This approach is especially critical for women’s health and longevity. Despite living longer than men, women spend roughly 25% more of their lives in poor health, with many chronic conditions closely linked to hormonal and metabolic regulation yet still poorly understood today.

“We’ve spent nearly a decade collecting real-world hormonal data — now totaling more than 30 million data points,” said Sylvia Kang, CEO and co-founder of Mira. “That data shows hormones influence far more than fertility. They sit at the center of how we feel, function, and age, which is why Ultra4 is just the beginning of a much broader vision for proactive, personalized health.”

At CES 2026, Mira will preview how Ultra4 expands into a comprehensive home lab for longevity, chronic condition management, and proactive care.

Visit Mira at CES Booth #54298 to learn more and meet the CEO and co-founder.

About Mira
Mira is a San Francisco-based hormonal health company pioneering data-driven solutions that help women understand their biology across every life stage – from menstruation and fertility to menopause and healthy aging. Founded in 2015, Mira is redefining how hormonal data is collected, analyzed, and applied to everyday health decisions. Learn more at miracare.com.

Click here for more details about our booth at: https://exhibitors.ces.tech/8_0/exhibitor/exhibitor-details.cfm?exhid=0013A00001TpieiQAB

Cision View original content:https://www.prnewswire.com/news-releases/mira-named-ces-innovation-awards-honoree-for-at-home-lab-quality-hormone-testing-302652982.html

SOURCE Quanovate Tech dba Mira

Market Opportunity
Mira Logo
Mira Price(MIRA)
$0.101
$0.101$0.101
-0.68%
USD
Mira (MIRA) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Is Putnam Global Technology A (PGTAX) a strong mutual fund pick right now?

Is Putnam Global Technology A (PGTAX) a strong mutual fund pick right now?

The post Is Putnam Global Technology A (PGTAX) a strong mutual fund pick right now? appeared on BitcoinEthereumNews.com. On the lookout for a Sector – Tech fund? Starting with Putnam Global Technology A (PGTAX – Free Report) should not be a possibility at this time. PGTAX possesses a Zacks Mutual Fund Rank of 4 (Sell), which is based on various forecasting factors like size, cost, and past performance. Objective We note that PGTAX is a Sector – Tech option, and this area is loaded with many options. Found in a wide number of industries such as semiconductors, software, internet, and networking, tech companies are everywhere. Thus, Sector – Tech mutual funds that invest in technology let investors own a stake in a notoriously volatile sector, but with a much more diversified approach. History of fund/manager Putnam Funds is based in Canton, MA, and is the manager of PGTAX. The Putnam Global Technology A made its debut in January of 2009 and PGTAX has managed to accumulate roughly $650.01 million in assets, as of the most recently available information. The fund is currently managed by Di Yao who has been in charge of the fund since December of 2012. Performance Obviously, what investors are looking for in these funds is strong performance relative to their peers. PGTAX has a 5-year annualized total return of 14.46%, and is in the middle third among its category peers. But if you are looking for a shorter time frame, it is also worth looking at its 3-year annualized total return of 27.02%, which places it in the middle third during this time-frame. It is important to note that the product’s returns may not reflect all its expenses. Any fees not reflected would lower the returns. Total returns do not reflect the fund’s [%] sale charge. If sales charges were included, total returns would have been lower. When looking at a fund’s performance, it…
Share
BitcoinEthereumNews2025/09/18 04:05
Franklin Templeton CEO Dismisses 50bps Rate Cut Ahead FOMC

Franklin Templeton CEO Dismisses 50bps Rate Cut Ahead FOMC

The post Franklin Templeton CEO Dismisses 50bps Rate Cut Ahead FOMC appeared on BitcoinEthereumNews.com. Franklin Templeton CEO Jenny Johnson has weighed in on whether the Federal Reserve should make a 25 basis points (bps) Fed rate cut or 50 bps cut. This comes ahead of the Fed decision today at today’s FOMC meeting, with the market pricing in a 25 bps cut. Bitcoin and the broader crypto market are currently trading flat ahead of the rate cut decision. Franklin Templeton CEO Weighs In On Potential FOMC Decision In a CNBC interview, Jenny Johnson said that she expects the Fed to make a 25 bps cut today instead of a 50 bps cut. She acknowledged the jobs data, which suggested that the labor market is weakening. However, she noted that this data is backward-looking, indicating that it doesn’t show the current state of the economy. She alluded to the wage growth, which she remarked is an indication of a robust labor market. She added that retail sales are up and that consumers are still spending, despite inflation being sticky at 3%, which makes a case for why the FOMC should opt against a 50-basis-point Fed rate cut. In line with this, the Franklin Templeton CEO said that she would go with a 25 bps rate cut if she were Jerome Powell. She remarked that the Fed still has the October and December FOMC meetings to make further cuts if the incoming data warrants it. Johnson also asserted that the data show a robust economy. However, she noted that there can’t be an argument for no Fed rate cut since Powell already signaled at Jackson Hole that they were likely to lower interest rates at this meeting due to concerns over a weakening labor market. Notably, her comment comes as experts argue for both sides on why the Fed should make a 25 bps cut or…
Share
BitcoinEthereumNews2025/09/18 00:36
OpenVPP accused of falsely advertising cooperation with the US government; SEC commissioner clarifies no involvement

OpenVPP accused of falsely advertising cooperation with the US government; SEC commissioner clarifies no involvement

PANews reported on September 17th that on-chain sleuth ZachXBT tweeted that OpenVPP ( $OVPP ) announced this week that it was collaborating with the US government to advance energy tokenization. SEC Commissioner Hester Peirce subsequently responded, stating that the company does not collaborate with or endorse any private crypto projects. The OpenVPP team subsequently hid the response. Several crypto influencers have participated in promoting the project, and the accounts involved have been questioned as typical influencer accounts.
Share
PANews2025/09/17 23:58